Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease

NCT00841373 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Retinal Ischemia

Interventions

PROCEDURE: Panretinal Photocoagulation
PROCEDURE: Panretinal Photocoagulation and intravitreal injection of ranibizumab

Sponsor

Southern New England Retina Associates

Collaborators

[object Object]